Department of Health (Hong Kong)

Jacobson Pharma Announces FY2022 Annual Results

Retrieved on: 
Wednesday, June 29, 2022

HONG KONG, June 29, 2022 - (ACN Newswire) - Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of essential medicines, specialty drugs and branded healthcare products, today announced the annual results of the Company and its subsidiaries (collectively the "Group") for the year ended 31 March 2022 ("FY2022" or the "Reporting Period").

Key Points: 
  • HONG KONG, June 29, 2022 - (ACN Newswire) - Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of essential medicines, specialty drugs and branded healthcare products, today announced the annual results of the Company and its subsidiaries (collectively the "Group") for the year ended 31 March 2022 ("FY2022" or the "Reporting Period").
  • About Jacobson Pharma Corporation Limited (Stock Code: 2633)
    Jacobson Pharma is a leading pharmaceutical company in Hong Kong vertically integrated and engaged in the research, development, production, sale and distribution of essential medicines and specialty drugs.
  • Jacobson Pharma has been a constituent stock of MSCI Hong Kong Micro Cap Index since 1 June 2017.
  • For more details about Jacobson Pharma, please visit the Group's website: http://www.jacobsonpharma.com
    Copyright 2022 ACN Newswire .

Jacobson Pharma Announces FY2022 Interim Results

Retrieved on: 
Friday, November 26, 2021

The Board has resolved to declare an increased interim dividend by 50% to HK1.2 cents per share for the six months ended 30 September 2021 (FY2021 Interim: HK0.8 cent).

Key Points: 
  • The Board has resolved to declare an increased interim dividend by 50% to HK1.2 cents per share for the six months ended 30 September 2021 (FY2021 Interim: HK0.8 cent).
  • About Jacobson Pharma Corporation Limited (Stock Code: 2633)
    Jacobson Pharma is a leading pharmaceutical company in Hong Kong vertically integrated with the research, development, production, sale and distribution of essential medicines and specialty drugs.
  • Jacobson Pharma has been a constituent stock of MSCI Hong Kong Micro Cap Index since 1 June 2017.
  • For more details about Jacobson Pharma, please visit the Group's website: http://www.jacobsonpharma.com
    Copyright 2021 ACN Newswire .

Rio Tinto and WA Government's Pilbara vaccination blitz commences

Retrieved on: 
Friday, September 17, 2021

Rio Tinto Iron Ore chief executive Simon Trott joined WA Health Minister Roger Cook today to open the Tom Price COVID-19 vaccination clinic aimed at boosting vaccination rates in the Pilbara, Western Australia.

Key Points: 
  • Rio Tinto Iron Ore chief executive Simon Trott joined WA Health Minister Roger Cook today to open the Tom Price COVID-19 vaccination clinic aimed at boosting vaccination rates in the Pilbara, Western Australia.
  • Vaccination bookings are available for all people who live or are currently in the region, including local and Aboriginal communities, Rio Tinto employees, contractors and their families.
  • Rio Tinto is working with the WA Government to establish similar clinics in Pannawonica and Dampier, and stands ready to provide logistical support as required to assist with the vaccination rollout in remote Aboriginal communities.
  • Rio Tinto Iron Ore chief executive Simon Trott urged all eligible community members in Tom Price to roll up for WA and play their part in boosting vaccination rates in the Pilbara.

Rio Tinto and WA Government launch industry first vaccination blitz

Retrieved on: 
Thursday, August 19, 2021

Rio Tinto is partnering with the Western Australian Government to launch a COVID-19 vaccination blitz targeting communities in the Pilbara and the fly-in fly-out workforce.

Key Points: 
  • Rio Tinto is partnering with the Western Australian Government to launch a COVID-19 vaccination blitz targeting communities in the Pilbara and the fly-in fly-out workforce.
  • Rio Tinto will work with the WA Government to finalise details in the coming weeks.
  • Rio Tinto Iron Ore chief executive Simon Trott said the company stood ready to support the WA Governments vaccination rollout in any way it can.
  • We are pleased to work in partnership with the WA Government on this industry-first vaccination blitz, which we expect will help boost vaccination rates in the Pilbara.